We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Imaging Technique Reduces Skin Tone Bias in Breast Cancer Detection

By LabMedica International staff writers
Posted on 19 Nov 2024
Print article
Image: Photoacoustic images of a splayed vessel structure underlying very light and dark skin tones (Photo courtesy of asquinha, Gubbi, and Bell, doi 10.1117/1.BIOS.2.1.012502)
Image: Photoacoustic images of a splayed vessel structure underlying very light and dark skin tones (Photo courtesy of asquinha, Gubbi, and Bell, doi 10.1117/1.BIOS.2.1.012502)

Breast cancer remains a significant global health issue, and early detection is key to successful treatment. Traditional imaging techniques like mammography often face challenges, particularly for women with dense breast tissue. Photoacoustic imaging, which uses a combination of light and sound to produce detailed images of breast tissue, presents a potential solution. However, recent research has identified a major issue: skin tone bias.

Researchers from Johns Hopkins University (Baltimore, MD, USA) conducted a study to assess how skin tone affects the visibility of breast cancer targets in photoacoustic imaging. Published in Biophotonics Discovery, the research evaluated three image reconstruction methods: fast Fourier transform (FFT)-based reconstruction, delay-and-sum (DAS) beamforming, and short-lag spatial coherence (SLSC) beamforming. The study involved simulations with various wavelengths (757, 800, and 1064 nm), target sizes (ranging from 0.5 to 3 mm), and skin tones (from very light to dark).

The findings revealed that traditional methods like FFT and DAS struggled to visualize small targets in darker skin tones, particularly at 757 and 800 nm wavelengths. Targets smaller than 3 mm were especially difficult to detect, with lower signal-to-noise ratios (SNR) and contrast-to-noise ratios (gCNR). In contrast, the 1064 nm wavelength showed notable improvements, particularly when paired with SLSC beamforming, enhancing the visibility of targets across all skin tones and providing clearer images with higher SNR and gCNR values.

The study findings offer promising implications for the future of breast cancer detection. By addressing the skin tone bias, photoacoustic imaging could become a more accurate and equitable tool for early diagnosis, benefiting women of all skin tones. The study highlights the importance of considering skin tone when designing next-generation imaging systems, ensuring more inclusive healthcare solutions.

“This work was motivated by a previously poor understanding of photoacoustic imaging performance under combined variations of small target sizes and darker skin tones,” said senior and corresponding author Muyinatu Bell. “Our results are enlightening, as we now have a better understanding of advanced photoacoustic imaging techniques and associated wavelengths necessary to detect small targets.”

Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
New
Centrifuge
Mikro 200
New
Urine Drug Test
Instant-view Buprenorphine Urine Drug Test

Print article

Channels

Molecular Diagnostics

view channel
Image: Three newly identified protein biomarkers have the potential to improve diagnostic tools for colorectal cancer (Photo courtesy of Adobe Stock)

New Protein Biomarkers to Improve Diagnostic Tools for Colorectal Cancer

Colorectal cancer is a leading cause of cancer-related deaths globally, and its incidence is expected to rise in the coming decades. This cancer begins when abnormal cells grow uncontrollably in the large... Read more

Microbiology

view channel
Image: The CRISPR-TB Blood Test provides accurate, rapid, and cost-effective diagnosis (Photo courtesy of 123RF)

CRISPR-TB Blood Test to Enable Early Disease Diagnosis and Public Screening

Tuberculosis (TB) continues to be a leading cause of global mortality, with 10.6 million new cases and 1.6 million deaths annually. Diagnosing TB remains difficult, with smear microscopy offering only... Read more

Industry

view channel
Image: The game-changing immunoassay diagnostics platform delivers results from whole blood sample in 10 minutes (Photo courtesy of SpinChip)

bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics

bioMérieux (Marcy l’Étoile, France) has agreed to acquire SpinChip Diagnostics (Oslo, Norway), the developer of a game-changing immunoassay diagnostics platform. The small benchtop analyzer is well adapted... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.